We tested the impact of inhibiting CXCR4 using AMD3100 with single-dose RT in orthotopic (intra-prostate and intra-osseous) PCa models in mice to reproduce the primary and metastatic tumor microenvironments more faithfully. This evidence concerns the gene CXCR4 and neoplasm.